Compounds and compositions as protein kinase inhibitors

Details Compounds and compositions as protein kinase inhibitors Compounds and compositions as protein kinase inhibitors

2004-10-01

2009-08-04

Morris, Patricia L (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S274100

Reexamination Certificate

active

07569593

ABSTRACT:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, BCR-Abl, PDGF-R, lck, SAPK2α, p38, TGFβ, KDR, c-Kit, b-RAF, c-RAF, FLT1 and FLT4 kinases.

REFERENCES:
patent: 6207687 (2001-03-01), Claiborne et al.
patent: 6235760 (2001-05-01), Feuerstein
patent: 7199137 (2007-04-01), Dean et al.
patent: 2003/0165873 (2003-09-01), Come
patent: 2306108 (1997-04-01), None
patent: WO95/03297 (1995-02-01), None
patent: WO9503297 (1995-02-01), None
patent: WO9735855 (1997-10-01), None
patent: WO9736587 (1997-10-01), None
patent: WO9901449 (1999-01-01), None
patent: WO0137835 (2001-05-01), None
patent: WO02/39954 (2002-05-01), None
Vippagunta et al., “Crystalliine Solidis”, Advanced Drug Delivery Reviews 48 (2001) 3-26.
Brittain ed, “Polymorphism, etc.,” NY: Marcel Dekker, Inc. , 1999, 183-226.
PubChem, Compound ID 11271644; retrieved from the internet, http://pubchehm.ncbi.nlm.nih.gov/summary/summary.cgi?cid=11271644; Mar. 8, 2007.
PubChem, Compound ID 11471239; retrieved from the internet, http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=11471239, Mar. 8, 2007.
PubChem, Compound ID 11439958; retrieved from the internet, http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=11439958, Mar. 8, 2007.
Gallagher T.F. et al, Bioorganic &Medicinal Chemistry, Jan. 1, 1997, 49-64, 5(1), Elsevier Science Ltd., GB.
Vippagunta S.R. et al, Advanced Drug Delivery Reviews, 2001, 48, 3-26, Elsevier.
Brittain Harry G. (ed), Polymorphism in Pharmaceutical Solids, 1999, 183-226, Marcel Dekker, New York.

Affiliated with

Also associated with

Rating

Compounds and compositions as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and compositions as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and compositions as protein kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4086159